Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J L Borgna

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Bulletin Du Cancer|January 1, 1994
[The elucidation of the antiestrogen and antitumoral mechanisms of tamoxifen]J L Borgna
Molecular and Cellular Endocrinology|October 1, 1980
High-affinity binding to the estrogen receptor of [3H]4-hydroxytamoxifen, an active antiestrogen metaboliteJ L Borgna, H Rochefort
Nature|July 16, 1981
Differences between oestrogen receptor activation by oestrogen and antioestrogenH Rochefort, J L Borgna
Molecular and Cellular Endocrinology|June 1, 1982
The dissociation rate of estrogen receptor-ligand complexes is increased by high concentrations of steroids and antiestrogensJ L Borgna, S Ladrech
Journal of Steroid Biochemistry|October 1, 1988
Differential inhibition of estrogen and antiestrogen binding to the estrogen receptor by diethylpyrocarbonateJ L Borgna, J Scali
The Journal of Biological Chemistry|January 25, 1981
Hydroxylated metabolites of tamoxifen are formed in vivo and bound to estrogen receptor in target tissuesJ L Borgna, H Rochefort
European Journal of Biochemistry|August 1, 1991
Differential interactions of estrogens and antiestrogens at the 17 beta-hydroxy or counterpart function with the estrogen receptorJ L Borgna, J Scali
Comptes Rendus Des Seances De L'Academie Des Sciences. Serie D, Sciences Naturelles|December 10, 1979
[In vivo occupation of estrogen receptors by hydroxylated metabolites of tamoxifen]J L Borgna, H Rochefort
La Semaine Des Hopitaux : Organe Fonde Par L'Association D'Enseignement Medical Des Hopitaux De Paris|March 1, 1984
[Effects and mechanism of action of antiestrogens in breast cancer]J L Borgna, H Rochefort
Pathologie-Biologie|November 1, 1983
[Effects and mechanism of action of antiestrogens in breast cancer]J L Borgna, H Rochefort
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Bulletin Du Cancer|January 1, 1994
[The elucidation of the antiestrogen and antitumoral mechanisms of tamoxifen]J L Borgna
Molecular and Cellular Endocrinology|October 1, 1980
High-affinity binding to the estrogen receptor of [3H]4-hydroxytamoxifen, an active antiestrogen metaboliteJ L Borgna, H Rochefort
Nature|July 16, 1981
Differences between oestrogen receptor activation by oestrogen and antioestrogenH Rochefort, J L Borgna
Molecular and Cellular Endocrinology|June 1, 1982
The dissociation rate of estrogen receptor-ligand complexes is increased by high concentrations of steroids and antiestrogensJ L Borgna, S Ladrech
Journal of Steroid Biochemistry|October 1, 1988
Differential inhibition of estrogen and antiestrogen binding to the estrogen receptor by diethylpyrocarbonateJ L Borgna, J Scali
The Journal of Biological Chemistry|January 25, 1981
Hydroxylated metabolites of tamoxifen are formed in vivo and bound to estrogen receptor in target tissuesJ L Borgna, H Rochefort
European Journal of Biochemistry|August 1, 1991
Differential interactions of estrogens and antiestrogens at the 17 beta-hydroxy or counterpart function with the estrogen receptorJ L Borgna, J Scali
Comptes Rendus Des Seances De L'Academie Des Sciences. Serie D, Sciences Naturelles|December 10, 1979
[In vivo occupation of estrogen receptors by hydroxylated metabolites of tamoxifen]J L Borgna, H Rochefort
La Semaine Des Hopitaux : Organe Fonde Par L'Association D'Enseignement Medical Des Hopitaux De Paris|March 1, 1984
[Effects and mechanism of action of antiestrogens in breast cancer]J L Borgna, H Rochefort
Pathologie-Biologie|November 1, 1983
[Effects and mechanism of action of antiestrogens in breast cancer]J L Borgna, H Rochefort
Pageof 3